Evaluation on the modified fatty acid SEFA 3002 as treatment for the inflammatory and fibrotic pathologies of nonalcoholic steatohepatitis in two complementary optimize mouse models
Laufzeit: 01.01.2016 - 31.12.2017
Kurzfassung
Evaluation on the modified fatty acid SEFA 3002 as treatment for the inflammatory and fibrotic pathologies of nonalcoholic steatohepatitis in two complementary optimize mouse models.
